[1]
“Therapeutic Drug Monitoring and Adverse Drug Reactions of Lithium in Patients Diagnosed with Bipolar Affective Disorder at a Tertiary Care Center in Eastern Nepal”, Nep. Med. Coll. J., vol. 28, no. 1, pp. 13–17, Mar. 2026, doi: 10.3126/nmcj.v28i1.92042.